Feature | June 11, 2013 | Greg Freiherr

Personalized Medicine Gets Up to Bat

Molecular imaging with PET/CT is leading off a new era of personalized medicine (photo courtesy of GE Healthcare).

In an increasingly impersonal world, where Facebook counts the number of friends we have and texting takes the place of conversation, who would not want personalized medicine? 

I liked it when visionaries first floated the idea more than a decade ago. That was when decoding the human genome was to be the cornerstone.
Looking into the genetic recesses of our humanity was to have revealed the differences among individuals, explaining why one person developed cancer while another did not. We were to gain an understanding of why some patients respond well to treatments when others do not, and learn how to best manage patients. We were told we might even be able to fix the faults in our genetic machinery and prevent some diseases altogether. 

Well, that didn’t pan out.

Now we’re hearing again about personalized medicine, but this time what the purveyors of this term have in mind might just happen, thanks to some semantic sleight-of-hand and a heavy dose of innovation. Radiology, rather than genomics, will be the building block of this future. 

Front and center will be molecular imaging with its increasing ability to quantify the uptake of biomarkers. This kind of number, namely standardized uptake values, has been around for a long time. But now positron emission therapy/computed tomography (PET/CT) quantitation is living up to its potential. It is distinguishing healthy from diseased tissue in a reliable and reproducible way, removing the uncertainty that goes with qualitative assessments and allowing the comparison of exams over time.

This capacity is being buoyed by an emerging legion of biomarkers that promises to dive into metabolic processes, providing possibly an unprecedented heads-up on disease and its extent.
It also might allow physicians to determine the effectiveness of therapy, as well as issue early warnings on the recurrence of disease signs after initially successful therapy.

And there may be more opportunities to personalize medicine than just molecular imaging. One may be magnetic resonance (MR) “fingerprinting,” a quick, radically new kind of MR that might one day scan — in just a few minutes — whole patients for early signs of cancer, multiple sclerosis and heart disease, scanning that might be done on a standard high-field scanner.

This possibility took shape in mid-March with the online publication of results from Case Western Reserve University School of Medicine in Cleveland, where researchers using a 1.5T scanner generated a “fingerprint” of health. The technique, according to the researchers, amounts to “an alternative way to quantitatively detect and analyze complex changes that can represent physical alterations of a substance or early indicators of disease.”

These were obtained by varying the scanner’s electromagnetic field, producing signals carrying information about key physical properties of in vivo tissues. The signals were analyzed, quantified and charted against patterns associated with health or disease. 

If the preliminary results hold up, MR fingerprinting would be the first truly novel MR development in decades. And the timing couldn’t be better, given the push for healthcare reform and its emphasis on cost reduction, disease prevention and early treatment. 

It’s hard to say when — or even whether — the new possibilities coming out of radiology will rise to the hype generated by decoding the human genome. But that may not matter. Semantics have redefined the venue of personalized medicine along with its expectations. 

It is encouraging in this context that the genomic home run mentality that used to characterize personalized medicine has begun to fade in favor of a radiological lineup that puts runners on base.

Play ball. 

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group. Read more of his views on his blog at www.itnonline.com.

Related Content

Novel PET Tracer Clearly Identifies and Tracks Bacterial Lung Infection

Representative PET/CT images of 18F-FDS and 18F-FDG in inflamed mice. Mice were inoculated with dead K. pneumoniae (10^8 CFU/mL). Imaging was performed for days 1, 2, 3 and 4 using 18F-FDG and 18F-FDS. CT images showed clear inflammation on day 2 and day 3 with corresponding high 18F-FDG uptake on PET. No significant uptake of 18F-FDS was detected for any of those 4 days. Credit: J Li et al., University of Louisville School of Medicine, Louisville, Ky.

News | PET-CT | January 22, 2018
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new...
American College of Radiology Releases New Patient-Oriented Appropriateness Criteria Summaries
News | Patient Engagement | January 19, 2018
January 19, 2018 — New Appropriateness Criteria (AC) Patient Summaries from the American College of Radiology (ACR) c
National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

Feature | Clinical Decision Support | January 18, 2018
January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
RSNA 2017 Celebrates Innovation in Radiology
News | Imaging | January 15, 2018
January 15, 2018 — The Radiological Society of North America’s...

Size comparison between 3-D printed prosthesis implant and a penny.

News | 3-D Printing | January 11, 2018
January 11, 2018 — Researchers using...
RSNA 2017 technical exhibits, expo floor, showing new radiology technology advances.
Feature | RSNA 2017 | January 11, 2018
January 11, 2018 — Here is a list of some of the key clinical study presentations, articles on trends and videos from
The artificial intelligence (AI) smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices.

The AI smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices. The size of the bleed volume indicates the urgency and type of treatment required.

Feature | Artificial Intelligence | January 10, 2018 | Greg Freiherr
Exhibitors at the 2017 Radiological Society of North American (RSNA) meeting rode the...
Upcoming radiology conferences, meetings and events. This photo is from the 2017 RSNA opening session.
News | January 09, 2018
ITN maintains a comprehensive listing of radiology specialty meetings on its website at ...
The new GE Healthcare Air Technology MRI coil design is 60 percent lighter than conventional coils, provides more flexibility and conforms to a patient’s anatomy like a blanket. The technology was unveiled at RSNA 2017 in late November.

The new GE Healthcare Air Technology MRI coil design is 60 percent lighter than conventional coils, provides more flexibility and conforms to a patient’s anatomy like a blanket. The technology was unveiled at RSNA 2017 in late November.

Feature | January 08, 2018 | Dave Fornell
Here is the list of the most popular articles and videos on the Imaging Technology News (ITN) magazine website from t
Overlay Init